Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q1 2013 · 10-Q
Revenue$499.70M$499.70M+2.8% vs Q1 2012 Net Income$20.20M$20.20M−34.8% vs Q1 2012 EPS Diluted$0.70$0.70−35.8% vs Q1 2012 Gross Profit$271,400,000−2.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flow$24,017,000−31.9% Free Cash Flowderived-$10,086,000N/M Margins · derivedGross margin54.3%−3.0 pt vs Q1 2012
Operating margin7.0%−4.1 pt vs Q1 2012
Net margin4.0%−2.3 pt vs Q1 2012
ended Mar 31, 2013 · filed May 10, 2013 · 40 d after period end